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Abstract 
Artificial Intelligence (AI) – the phenomenon of machines being able to solve problems                         
that require human intelligence – has in the past decade seen an enormous rise of                             
interest due to significant advances in effectiveness and use. The health sector, one of                           
the most important sectors for societies and economies worldwide, is particularly                     
interesting for AI applications, given the ongoing digitalisation of all types of health                         
information. The potential for AI assistance in the health domain is immense, because                         
AI can support medical decision making at reduced costs, everywhere. However, due to                         
the complexity of AI algorithms, it is difficult to distinguish good from bad AI-based                           
solutions and to understand their strengths and weaknesses, which is crucial for                       
clarifying responsibilities and for building trust. For this reason, the International                     
Telecommunication Union (ITU) has established a new Focus Group on "Artificial                     
Intelligence for Health" (FG-AI4H) in partnership with the World Health Organization                     
(WHO). Health and care services are usually the responsibility of a government - even                           
when provided through private insurance systems - and thus under the responsibility of                         
WHO/ITU member states. FG-AI4H will identify opportunities for international                 
standardization, which will foster the application of AI to health issues on a global scale.                             
In particular, it will establish a standardized assessment framework with open                     
benchmarks for the evaluation of AI-based methods for health, such as AI-based                       
diagnosis, triage or treatment decisions. 
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Introduction 
"The enjoyment of the highest attainable standard of health" is a basic human right (WHO                             
Constitution, 1946). Good health for everyone has for centuries been a key goal of most                             
governments, and public health breakthroughs such as vaccination are generally credited with                       
having saved – and continuing to save – billions of lives. In many countries today, the                               
healthcare industry is the largest and/or fastest growing industry, increasingly often accounting                       
for more than ten percent of the gross domestic product. It is thus not surprising that the                                 
healthcare sector is a key area of application, when a technology reaches new levels of                             
performance, as is the case with modern AI. Given the size of the health sector, the potential                                 
economic opportunities are immense. The potential for leveraging new technology for the                       
common good by improving public health can also be enormous. It is therefore prudent to look                               
at the potential of AI in helping solve health-related issues. This short paper describes the                             
current applications of AI in the health domain and discuss challenges and how to address                             
these in order to unlock the full potential of the technology. 
Artificial Intelligence 
The term ​artificial intelligence is not new. As an academic field, it dates back to at least the                                   
mid-20​th century, and has since gone through multiple cycles of substantial progress, followed                         
by inflated expectation, and then disappointment. A combination of new machine learning                       
algorithms, increased computational power, and an explosion in the availability of very large                         
data sets (“big data”), as a consequence of the digitalisation of health information, has led to                               
recent stunning advances, with demonstrations of machines achieving human-level                 
competence at solving clearly defined tasks across many domains. The current cycle is                         
primarily driven by the extremely impressive progress recently made by deep learning, a branch                           
of machine learning that very effectively uses artificial neural networks to address harder                         
problems than ever before. Applications of deep learning have achieved human or superhuman                         
performance in many fields such as image recognition and natural language processing.                       
Importantly, the neural network parameters are tuned in an automated process of iterative                         
training. In many cases, no expert-level knowledge is used in the training process, other than                             
direct input and output parameters (e.g. sets of pixels and their associated labels), giving rise to                               
the so-called “end-to-end” learning. In other words, the networks learn to go directly from one                             
end – the input – to the other end – the output – without requiring any domain-specific                                 
expertise in between. The resulting network structures are generally very large, with oftentimes                         
billions of parameters, and of such complexity that it is impossible to describe in simple terms                               
how they work, which has led to new challenges concerning their explainability and                         
interpretability. 
AI for Health 
The recent digitalisation of all types of health information and the fact that computers are                             
increasingly able to interpret images and text as accurately as humans​1,2 opens up countless                           
avenues for AI applications in health. Much of the recent work on AI in health has thus gone into                                     
applications that revolve around image interpretation and natural language understanding. In                     
the field of medical image analysis, one of the most publicized studies was by Esteva et al.​3​,                                 
demonstrating the accurate classification of skin lesions using a deep neural network that was                           
trained on clinical images, and assessing its performance by comparing its classifications to                         
those made by board-certified dermatologists, revealing the network had reached human                     
accuracy levels.  
 
A survey​4 published in 2017 reviewed over 300 papers using deep learning in medical image                             
analysis, typically for detection, segmentation, or classification tasks. The reviewed papers                     
covered the analysis of X-ray, CT, MRI, digital pathology, cardiac, abdominal, musculoskeletal,                       
fetal, dermatological and retinal images. In language understanding, the areas of biomedical                       
text mining, electronic health record analysis, sentiment analysis on internet-derived data, and                       
medical decision support systems have shown promising results​5​. Furthermore, AI methods can                       
automatically interpret laboratory results (ranging from standard blood testing to recent                     
advances in high-throughput genomics and proteomics) and time series (e.g.                   
electrocardiogram, temperature, oxygen saturation, blood pressure).  
 
A large part of the world’s population has access to devices that can utilize compute-intense                             
AI-powered applications, considering the ubiquity of computers and smartphones connected via                     
the internet to powerful computing clusters. For example, relatively accurate detection of skin                         
lesions using a state-of-the art camera-equipped mobile phone is technologically feasible, and                       
medical chatbots are already on the market that can answer basic medical questions. Given the                             
speed at which AI-based algorithms can be developed, improved, and deployed, the technology                         
has the potential for first-class medical decision making that is accessible worldwide and                         
affordable to the entire global population​6​. 
 
While this progress is exciting, the potential of AI for health also faces a number of challenges.                                 
In particular, deep learning models are famously hard to interpret and explain - which may                             
substantially hinder their acceptance when facing critical or even vital decisions. Thus,                       
interpretability, explainability, and proven robustness (e.g. to outliers and to adversarial attacks)                       
are crucial aspects that have to be considered for trustworthiness. Moreover, health data are                           
sensitive and subject to privacy laws. Therefore, access to sufficient training data is a major                             
limiting factor for the predictive performance of models on data previously unseen.  
 
This problem is complicated further because most modern AI applications are based on                         
supervised learning and rely on data that are labeled. In the health domain, labels can typically                               
be given only by qualified specialists, in contrast, e.g., to simple object recognition, where                           
photographs can be labeled by legions of laypersons. In addition, machine learning approaches                         
must take into account the biases​7 that both text and image-based medical data most likely                             
contain. In machine learning, algorithms and training data have to be considered in                         
combination. The algorithms can not extrapolate, but can only learn patterns that are present in                             
the training data, which need to be of high quality, sufficiently large to learn the myriad of                                 
parameters of the “data-hungry” algorithms, and theoretically should cover all possible                     
instances including outliers. 
 
The ​Focus Group on "Artificial Intelligence for Health" (FG-AI4H) established by ITU in                         
partnership with WHO aims to meet the challenges by identifying opportunities for international                         
standardization. The initiative works on the premise that the broad adoption would benefit from                           
a standardized and transparent evaluation of the AI methods. It should be noted that the Focus                               
Group neither intends to specify the AI for health algorithms themselves as an ITU                           
Recommendation, nor to standardize medical data formats, nor to establish performance                     
criteria of hardware running the AI algorithms. 
 
AI can support medical diagnostics and decision making by mapping from input data to output                             
variables. Exemplary input data are images, text, time series, SNOMED CT, or HPO codes.                           
Exemplary output variables are ICD or ICHI codes, triage tags, or other labels, depending on the                               
use case. For instance, an AI-algorithm could map the input data to a diagnosis (represented by                               
an ICD code), or it could make a treatment decision (represented by an ICHI code) via a                                 
diagnosis: 
 
 
Figure 1: Mapping input data to diagnosis and treatment decision 
 
Hence, benchmarking could be conducted without the need to disclose or standardize the                         
AI-algorithms themselves. Instead, standardized input data sets could be created with                     
corresponding confirmed standardized diagnosis or decision codes or other variables per                     
patient. The data could be split into public training and private test sets. Performance metrics                             
for comparisons could be created, which would reflect the quality of the mapping (accuracy,                           
reproducibility, robustness, absence of bias, explainability, interpretability etc.) as well as timing                       
aspects and other costs.  
 
For the establishment of a benchmarking framework, it is necessary to first identify potential                           
health problems to which AI interventions can be applied and assessed. The targeted problems                           
and possible solutions should be scalable. Structured medical data need to be collected and                           
open benchmarks have to be developed for the identified use cases and solutions.                         
Subsequently the benchmarking system itself has to be implemented. 
Benchmarking Pipeline 
Here, we outline a proposal for a benchmarking pipeline that will be applicable to many different                               
scenarios. At the core of the evaluation framework lies a secret test set on which models will be                                   
evaluated.  
 
The pipeline is summarized in the following figure: 
 
 
Figure 2: A Benchmarking Pipeline 
 
 
 
The benchmarking pipeline consists of the following steps:  
 
1. FG-AI4H enables creation of public data repositories wherever possible 
Most modern approaches to building AI models involve training on existing data sets.                         
FG-AI4H will work to enable the creation of publicly available high-quality data sets to                           
foster the creation of a diverse ecosystem of actors who want to participate in the                             
benchmarking process.  
 
2. Participants build AI models based on public data and other (private) data sources 
Participants will train their models based on a clear problem definition which is crucial                           
for the success of a benchmark. This needs to include the quantitative measure                         
according to which the benchmark will be assessed.  
 
3. Models are submitted to a benchmarking platform like crowdAI, which checks the                       
eligibility of the model 
Models will be submitted to agreed upon benchmarking platforms (such as                     
www.crowdAI.org​). The eligibility of the models must be defined on a case-by-case                       
basis, but should include minimum requirements such as a maximum run time, and a                           
maximum memory requirement. 
 
4. Eligible models are executed and evaluated on secret test data, managed by FG-AI4H 
The benchmarking platform executes the model on the secret test set. The creation and                           
governance of this secret test set will be managed by subgroups of FG-AI4H. This secret                             
test set represents the gold standard data set for the benchmark.  
 
5. Participant receives evaluation, model has been benchmarked 
After having executed the model on the secret data set, the benchmarking platform                         
returns the evaluation results to the participant, allowing for further developments to                       
improve the model. 
 
6. Central leaderboard allows comparison of model performances 
The Benchmarking platform allows for the comparison of the models’ performance on a                         
central leaderboard, or using a pass/fail scoring. The relevant subgroups of FG-AI4H can                         
define baselines against which models can be assessed.  
 
It should be noted that this pipeline is meant to provide a broad overview only - developing the                                   
details, and communicating and documenting those clearly, is one of the key achievable goals                           
of FG-AI4H and its working groups. 
Conclusion 
Artificial Intelligence for Health (AI4H) offers new ways to address the shortage of medical                           
professionals, which becomes more serious due to demographic changes and population                     
growth. The technology has the potential to significantly improve and support medical                       
diagnostics and treatment decision processes based on digital data. However, AI4H is rarely                         
deployed in practice at a global scale – so far – due to legal, business, technical, or other                                   
constraints. 
 
The new Focus Group on Artificial Intelligence for Health will work towards a standardized                           
assessment of AI-based solutions for health, which will assure its quality, foster the adoption in                             
practice and have a strong positive impact on global health. The FG-AI4H was founded in July                               
2018 by the International Telecommunication Union (ITU) in partnership with the World Health                         
Organization (WHO), the United Nations specialized agencies for ICTs and Health, respectively.                       
Participation in FG-AI4H is open to all researchers, engineers, practitioners, entrepreneurs and                       
policy makers.  
 
FG-AI4H will identify common health-specific domains (e.g. general diagnosis, specialty                   
diagnosis [e.g. dermatology], health natural language processing, general clinical encounter                   
note data extraction and coding, Rx coding, lab coding, etc.) and for each domain it will work for                                   
the sourcing of test data, select current gold standard test success rates (e.g. how does a                               
professional score on this test data), set benchmark rates for AI system (to be acceptable for                               
decision support, to be acceptable for autonomous operation), and define acceptable fail                       
modes (e.g. alert human operator if below a given confidence threshold). 
 
In addition to medical, scientific and technical aspects, policy, regulatory, cultural, business and                         
other practical aspects must be considered in relationship to standardization efforts. Therefore,                       
the FG-AI4H will establish liaisons at an early stage with selected standards bodies, forums,                           
consortia, regulators, health professionals, core research as well as patient organizations,                     
engineering teams, entrepreneurs and policy makers. Registries for reporting serious adverse                     
events and guidance documents for national administrations will support the safe and                       
appropriate use of AI in healthcare. 
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